Clinical Trial Update: BATTLE-FL: Front-Line Biomarker-Integrated Treatment Study in Non Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial update for BATTLE-FL, a front-line biomarker-integrated treatment study in non-small cell lung cancer, completed with posted results in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-05-08